Loading...
XBRUONTEX
Market cap679mUSD
Dec 20, Last price  
8.02EUR
1D
0.50%
1Q
-7.71%
Jan 2017
-71.61%
IPO
-57.27%
Name

Ontex Group NV

Chart & Performance

D1W1MN
XBRU:ONTEX chart
P/E
18.70
P/S
0.36
EPS
0.43
Div Yield, %
0.00%
Shrs. gr., 5y
0.43%
Rev. gr., 5y
-4.77%
Revenues
1.79b
+7.33%
1,217,600,0001,309,000,0001,491,900,0001,615,900,0001,689,300,0001,993,000,0002,355,400,0002,292,100,0002,281,300,0002,086,800,0002,026,500,0001,672,200,0001,794,700,000
Net income
35m
P
-48,200,000-8,500,00022,900,0008,600,00098,600,000119,700,000128,400,00097,000,00037,300,00054,000,000-61,900,000-148,700,00034,800,000
CFO
161m
+467.49%
80,200,00087,600,000134,500,000153,600,000180,600,000195,500,000169,300,000169,700,000239,000,000190,500,000130,300,00028,300,000160,600,000
Dividend
Jun 01, 20220.8 EUR/sh
Earnings
Feb 06, 2025

Profile

Ontex Group NV provides personal hygiene solutions for baby, feminine, and adult care in Western Europe, Eastern Europe, the Americas, Mexico, the United Kingdom, Italy, France, and internationally. It offers baby care products, such as baby diapers and pants, and wet wipes under the Baby Pants, Bbtips, Bio Baby, Chicolastics, Canbebe, Cremer Disney, Helen Harper, Kiddies, Little Big Change, Moltex, Pom Pom, Sapeka, and Mônica brands; and feminine care products, including sanitary towels, panty liners, and tampons under the Fiore, Mia, NAT, Sincere, and Silhouette brand names. The company also provides adult incontinence products comprising adult pants and diapers, incontinence towels, and bed protection products under the A Lovely Day, Adultmax Maturidade, Affective, Bigfral, iD, Canped, Affective, Lille Healthcare, Kylie, Serenity, Orizon, and Moviment brands; and as produces and sells face masks. It sells its products to consumers, retailers, and institutional and private healthcare providers, as well as offers products under retailer brands. Ontex Group NV was founded in 1979 and is headquartered in Aalst, Belgium.
IPO date
Jun 25, 2014
Employees
7,500
Domiciled in
BE
Incorporated in
BE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,794,700
7.33%
1,672,200
-17.48%
2,026,500
-2.89%
Cost of revenue
1,684,900
1,655,500
1,944,900
Unusual Expense (Income)
NOPBT
109,800
16,700
81,600
NOPBT Margin
6.12%
1.00%
4.03%
Operating Taxes
16,300
28,400
19,000
Tax Rate
14.85%
170.06%
23.28%
NOPAT
93,500
(11,700)
62,600
Net income
34,800
-123.40%
(148,700)
140.23%
(61,900)
-214.63%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
141,100
145,400
46,700
Long-term debt
786,500
1,012,100
998,700
Deferred revenue
22,000
Other long-term liabilities
35,700
13,900
300
Net debt
805,600
1,007,700
795,200
Cash flow
Cash from operating activities
160,600
28,300
130,300
CAPEX
(96,500)
(62,400)
(56,500)
Cash from investing activities
119,000
(57,700)
25,300
Cash from financing activities
(309,800)
(9,500)
(332,400)
FCF
220,600
(274,400)
162,600
Balance
Cash
97,200
149,500
246,700
Long term investments
24,800
300
3,500
Excess cash
32,265
66,190
148,875
Stockholders' equity
521,500
781,800
1,415,800
Invested Capital
1,718,335
1,820,310
1,819,825
ROIC
5.28%
3.27%
ROCE
6.27%
0.88%
4.10%
EV
Common stock shares outstanding
82,857
81,030
80,950
Price
7.61
21.96%
6.24
-10.73%
6.99
-36.45%
Market cap
630,543
24.71%
505,627
-10.64%
565,841
-36.52%
EV
1,436,143
1,815,327
1,694,241
EBITDA
180,500
87,100
169,300
EV/EBITDA
7.96
20.84
10.01
Interest
55,500
41,700
40,200
Interest/NOPBT
50.55%
249.70%
49.26%